Doctor profile · Federal record

Dr. Mark Laftavi, MD

Transplant Surgery Physician · Transplant Surgery Physician · Las Vegas, NV

  • NPI 1093765448
  • 20 yrs on file
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
901 N. Rancho Ln. Ste. 250
Las Vegas, NV 89106
(702) 383-2224
fax (702) 383-3035
Mailing address
1800 W. Charleston Blvd.
Las Vegas, NV 89102

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
November 24, 2021
Specialty taxonomy
204F00000X — NUCC code
State licenses (2)
Nevada #21500 · New York #216816
Medicaid
NY #02162370

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1093765448. Last verified May 11, 2026.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$12,373
Transactions
5
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
Sanofi-Aventis U.S. LLC 5 $12,372.70

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$10,938
Travel and Lodging
$1,285
Food and Beverage
$150

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Laftavi's medical specialty?
Dr. Mark Laftavi practices Transplant Surgery Physician in Las Vegas, NV.
Where does Dr. Mark Laftavi practice?
Dr. Mark Laftavi practices at 901 N. Rancho Ln. Ste. 250, Las Vegas, NV 89106. Office phone: 7023832224.
What is Dr. Mark Laftavi's NPI?
Dr. Mark Laftavi's National Provider Identifier (NPI) is 1093765448, issued by NPPES.

Methodology · sources used on this page

All figures on this page come from publicly available federal datasets. We do not edit, score, or summarise the underlying data. Profile generated Jul 23, 2026.

NPPES Provider identifiers and practice info May 11, 2026
Open Payments Industry payments to providers (Sunshine Act) May 11, 2026
Medicare Procedure Utilization Services and allowed amounts by HCPCS May 11, 2026
Medicare Part D Prescription drug claims May 11, 2026
CMS MIPS Quality performance scores May 11, 2026
OIG LEIE Federal exclusion / sanctions list May 11, 2026

Information based on publicly available federal data. Not medical advice. Report incorrect data ›